In line with our results, a prospective 6-year follow-up analysis from 3 Finnish population-based cohorts (including the Northern Finland Birth Cohort 1966) indicates that circulating SHBG is predictive of the degree of insulin resistance and glycemia and that elevated SHBG has protective role on T2DM risk (49). The gene discussed is SHBG; the disease is Insulin resistance.